Author
Listed:
- Stephen G. Parker
(The University of New South Wales
The University of New South Wales
ARC Centre of Excellence in Convergent Bio-Nano Science and Technology)
- Ying Yang
(The University of New South Wales)
- Simone Ciampi
(The University of New South Wales)
- Bakul Gupta
(The University of New South Wales
The University of New South Wales
ARC Centre of Excellence in Convergent Bio-Nano Science and Technology)
- Kathleen Kimpton
(The University of New South Wales
ARC Centre of Excellence in Convergent Bio-Nano Science and Technology
The University of New South Wales)
- Friederike M. Mansfeld
(The University of New South Wales
ARC Centre of Excellence in Convergent Bio-Nano Science and Technology
The University of New South Wales
Monash University)
- Maria Kavallaris
(The University of New South Wales
ARC Centre of Excellence in Convergent Bio-Nano Science and Technology
The University of New South Wales)
- Katharina Gaus
(The University of New South Wales
The University of New South Wales
The University of New South Wales)
- J. Justin Gooding
(The University of New South Wales
The University of New South Wales
ARC Centre of Excellence in Convergent Bio-Nano Science and Technology)
Abstract
For many normal and aberrant cell behaviours, it is important to understand the origin of cellular heterogeneity. Although powerful methods for studying cell heterogeneity have emerged, they are more suitable for common rather than rare cells. Exploring the heterogeneity of rare single cells is challenging because these rare cells must be first pre-concentrated and undergo analysis prior to classification and expansion. Here, a versatile capture & release platform consisting of an antibody-modified and electrochemically cleavable semiconducting silicon surface for release of individual cells of interest is presented. The captured cells can be interrogated microscopically and tested for drug responsiveness prior to release and recovery. The capture & release strategy was applied to identify rare tumour cells from whole blood, monitor the uptake of, and response to, doxorubicin and subsequently select cells for single-cell gene expression based on their response to the doxorubicin.
Suggested Citation
Stephen G. Parker & Ying Yang & Simone Ciampi & Bakul Gupta & Kathleen Kimpton & Friederike M. Mansfeld & Maria Kavallaris & Katharina Gaus & J. Justin Gooding, 2018.
"A photoelectrochemical platform for the capture and release of rare single cells,"
Nature Communications, Nature, vol. 9(1), pages 1-9, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-04701-y
DOI: 10.1038/s41467-018-04701-y
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-04701-y. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.